Notable webinars: Pediatric drug development; Drug delivery systems
Dear All, The high-value webinars below have just crossed my radar. First up, we have a very important 2-part webinar on pediatric antibacterial drug development entitled “Improving
Dear All, The high-value webinars below have just crossed my radar. First up, we have a very important 2-part webinar on pediatric antibacterial drug development entitled “Improving
Dear All, I want to call your attention to next week’s AMDAC (Antimicrobial Drugs Advisory Committee) for rezafungin. This meeting is Tue 24 Jan 2023,
Long and wonkish note alert — please refresh your coffee before you start reading! Dear All: I was able to attend and speak at the
(15 Apr 2021 update: WHO have today released a 2020 update to the report discussed in this newsletter.) Dear All, WHO has today released two
Dear All, First up for today, WHO’s GLASS (Global Antimicrobial Resistance and Use Surveillance System) have released an update to their ongoing work that provides
Dear All, Based on a 2020 RFP, we’ve known that WHO was building a fungal priority pathogen list (PPL). Well, now the list has been
Dear All: The new WHO priority pathogen list for R&D has been released! It’s entirely focused on bacteria both otherwise has a lot of similarity
Dear All, A quick note today to call your attention to an upcoming webinar that will be of wide interest. Substantial new details have been
Dear All, We have a 3-part discussion today on the theme of “I want a new drug … so how do I find it?” Off
Dear All: I have learned that the program for IDWeek 2022 will have specific dedicated pipeline sessions for therapeutics and diagnostics. The online details are